(0.25%) 5 321.41 points
(0.17%) 39 873 points
(0.22%) 16 833 points
(-0.25%) $79.06
(-1.42%) $2.63
(0.01%) $2 426.10
(0.71%) $32.31
(-0.08%) $1 060.00
(0.02%) $0.921
(0.00%) $10.66
(-0.01%) $0.787
(0.29%) $90.49
Live Chart Being Loaded With Signals
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 683 289 |
Vidutinė apimtis | 581 877 |
Rinkos kapitalizacija | 4.53B |
EPS | $0 ( 2024-05-07 ) |
Kita pelno data | ( $0 ) 2024-07-30 |
Last Dividend | $9.00 ( 2008-01-09 ) |
Next Dividend | $0 ( N/A ) |
P/E | -287.49 |
ATR14 | $0.184 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-10 | Mccormick Shawn | Buy | 2 500 | Common Stock |
2024-05-10 | Mccormick Shawn | Sell | 2 500 | Stock Option (Right to Buy) |
2024-05-02 | Burks Cynthia | Buy | 716 | Common Stock |
2024-05-02 | Tansey Casey M | Buy | 716 | Common Stock |
2024-05-02 | Ellis Gary Lee | Buy | 716 | Common Stock |
INSIDER POWER |
---|
5.08 |
Last 100 transactions |
Buy: 146 836 | Sell: 127 702 |
Tūris Koreliacija
Inspire Medical Systems Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Inspire Medical Systems Koreliacija - Valiuta/Žaliavos
Inspire Medical Systems Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $624.80M |
Bruto pelnas: | $528.22M (84.54 %) |
EPS: | $-0.720 |
FY | 2023 |
Pajamos: | $624.80M |
Bruto pelnas: | $528.22M (84.54 %) |
EPS: | $-0.720 |
FY | 2022 |
Pajamos: | $407.86M |
Bruto pelnas: | $341.74M (83.79 %) |
EPS: | $-1.600 |
FY | 2021 |
Pajamos: | $233.39M |
Bruto pelnas: | $200.12M (85.74 %) |
EPS: | $-1.540 |
Financial Reports:
No articles found.
Inspire Medical Systems Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $9.00 | 2008-01-09 |
Last Dividend | $9.00 | 2008-01-09 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $9.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.05 | -- |
Div. Sustainability Score | 7.27 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 3.46 | -- |
Year | Amount | Yield |
---|---|---|
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend King | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
SCM | Dividend Royal | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
PVL | Dividend Royal | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0238 | 1.500 | -0.476 | -0.714 | [0 - 0.5] |
returnOnAssetsTTM | -0.0229 | 1.200 | -0.765 | -0.918 | [0 - 0.3] |
returnOnEquityTTM | -0.0282 | 1.500 | -1.424 | -2.14 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 7.93 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 7.12 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.43 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0357 | -1.500 | 9.40 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -8.39 | 1.000 | -4.22 | -4.22 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.177 | 2.00 | 9.61 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.111 | 2.00 | 9.94 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0416 | -1.500 | 9.83 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.847 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0545 | 1.000 | -3.09 | -3.09 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.423 | 1.000 | 3.21 | 3.21 | [0.2 - 2] |
assetTurnoverTTM | 0.964 | 0.800 | 6.91 | 5.53 | [0.5 - 2] |
Total Score | 7.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -292.29 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0282 | 2.50 | -0.915 | -2.14 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.111 | 2.00 | 9.96 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.177 | 2.00 | 9.61 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -22.92 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0527 | 1.000 | -1.181 | 0 | [0.1 - 0.5] |
Total Score | -0.347 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.